focus -WSS

focus

author：fashion 2025-08-17 00:02:28 - browse：85987

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025.

The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%.

Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm. The medicine was the first of a new class of disease-modifying Alzheimer’s drugs to be approved by the Food and Drug Administration. But doubts about the quality of the data behind the medicine meant that Medicare wouldn’t pay for it and doctors did not prescribe it. The resulting financial disaster cleaned out Biogen’s executive suite.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Time to name cancers by genetics, not organ of origin, expert says

WSS

Medicare drug price negotiation’s day in court

Vertex non

Key House Republican on health care plans exit from Congress

To avoid data mishandling cases, universities eye AI and other tools

A disappointing year of Humira biosimilars

New Ultima Genomics DNA sequencer can read genome for $100

entertainment

focus

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What we need to know about Arena Bioworks

In Memoriam: Notable people who died in 2023

Time to name cancers by genetics, not organ of origin, expert says

ChatGPT in medicine: STAT answers readers' burning questions

The real point of Kenneth Smith’s execution by nitrogen gas

Medical leaders decry Supreme Court decision on affirmative action

Some dementia cases could be undiagnosed liver disease

Tori Bowie and the unacceptable rates of Black maternal death

Vertex non

entertainment

Commercial surrogacy can be ethical, despite pope’s claims

Commercial surrogacy can be ethical, despite pope’s claims

Some dementia cases could be undiagnosed liver disease

Novo Nordisk to expand supply of Wegovy for U.S. patients

Why did Pfizer dish out millions for a Super Bowl ad?

Vertex non

hotspot

leisure time

focus

Wikipedia